ARTÍCULO

Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study

AUTORES/AS

Dr. José Manuel Olivares, Dra. Ana González-Pinto, Mario Páramo

• VER VÍDEO

• esquizofrenia
• aripiprazol
• persistencia
• predictores

ARTÍCULO

Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)

AUTORES/AS

Kai-Chun Yang, Yin-To Liao, Yen-Kuang Yang et al.

• esquizofrenia
• ILP
• Recaídas

ARTÍCULO

Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders

AUTORES/AS

Olcay Şenay Şahin, Zhala Mursalova, Shahriyar Gadimov et al.

• esquizofrenia
• ILP
• Adherencia

ARTÍCULO

Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study

AUTORES/AS

L. Malandain, M. Leygues, F. Thibaut

• esquizofrenia
• DDD
• politerapia

ARTÍCULO

Structure and Functioning of Acute Inpatient Psychiatric Units in Spain: Qualitative Study

AUTORES/AS

Ricardo Campos Ródenas, Roberto Rodríguez, Iluminada Corripio et al.

• IUPA
• Modelos de salud
• Agudos

ARTÍCULO

Once-Monthly Long-Acting injectable Aripiprazole for the Treatment of Patients with Schizoprenia and Co-occurring Substance Use Disorders: A multicentre, Observational Study

AUTORES/AS

Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega et al.

• VER VÍDEO

• Consumo
• ILP
• esquizofrenia